Film-coated tablets – 300 mg
Aritmine P contains propafenone hydrochloride as active substance, which belongs to a group of medicines called antiarrhythmics (class Ic). It acts by stabilizing the membrane of cardiac cells. Propafenone also demonstrates some β-blocking and calcium-channel blocking activity.
Aritmine P is indicated for the management of ventricular arrhythmias.
It is also indicated for the management of paroxysmal supraventricular tachyarrhythmias which include paroxysmal atrial flutter or fibrillation and paroxysmal re-entrant tachycardias involving the AV node or accessory pathway, where standard therapy is ineffective or contraindicated.